Celltrion Inc.

Jung Sun Ahn

Shin Jae Chang

Soo Young Lee

Pan Kyeom Kim

Man Ki Song

Byung Pil Lim

Min Joo Choo

Sun Ju Keum

Jung Ah Choi

Sang Tae Park

Eun Bee Park

This invention relates to a rabies virus G protein epitope and a rabies-virus-neutralizing binding molecule that binds specifically thereto, wherein different epitope sites of rabies virus G protein are identified and binding molecules that bind thereto and a cocktail thereof can be found to retain neutralizing activity against various rabies viruses.

Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically thereto

This invention relates to an adjuvant composition containing at least one binding molecule for neutralizing influenza virus and a vaccine composition containing the same. The composition containing at least one binding molecule for neutralizing influenza virus is capable of increasing the effects of a vaccine, and can thus be used as an adjuvant, which increases an immune response upon vaccine administration, and is very useful in the prevention of diseases caused by viruses.

Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same

Growing community of inventors

Incheon, South Korea

Jung Sun Ahn